# Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2

Study · id `cardio:ct-nct05843682` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05843682](<https://clinicaltrials.gov/study/NCT05843682>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05843682

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.

## Technical summary

Registry record NCT05843682. Randomized; no masking; primary purpose health services research. Start 2022-10-07 (actual); primary completion 2023-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05843682, source copy `cardio:ctgov-nct05843682-2023-05-06`, retrieved 2026-10-26)
- Started: 2022-10-07 (actual) (ClinicalTrials.gov record NCT05843682, source copy `cardio:ctgov-nct05843682-2023-05-06`, retrieved 2026-10-26)
- Primary completion: 2023-08-31 (anticipated) (ClinicalTrials.gov record NCT05843682, source copy `cardio:ctgov-nct05843682-2023-05-06`, retrieved 2026-10-26)
- Completion: 2024-02-29 (anticipated) (ClinicalTrials.gov record NCT05843682, source copy `cardio:ctgov-nct05843682-2023-05-06`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT05843682, source copy `cardio:ctgov-nct05843682-2023-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05843682-2023-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2
- Acronym: Hyper2
- Condition: Essential Hypertension
- Condition: Metabolic Cardiovascular Syndrome
- Condition: Heart Disease Risk Factors
- Intervention (Device): Using the Avatr App
- Lead sponsor: University of Sao Paulo General Hospital
- Lead sponsor class: OTHER
- Collaborator: InCor Heart Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of Sao Paulo General Hospital (`cardio:org-university-of-sao-paulo-general-hospital`)
- Registry lists this organization as a collaborator: InCor Heart Institute (`cardio:org-incor-heart-institute`)

## Provenance

Content hash: 300f8e804e39aa9623ab5e3953a7044fdae2236d5a17d56c77c676b5d4faf655
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
